EpiVacCorona

Summary

EpiVacCorona ranks in the top 2% of general entities by monthly Wikipedia readership (12 views/month).^[1]

Key Facts

• EpiVacCorona's image is recorded as Epivakkorona ampule (cropped).jpg^[2].
• EpiVacCorona's developer is recorded as State Research Center of Virology and Biotechnology VECTOR^[3].
• EpiVacCorona's subclass of is recorded as COVID-19 vaccine^[4].
• EpiVacCorona's subclass of is recorded as protein subunit vaccine^[5].
• EpiVacCorona's subclass of is recorded as vaccine candidate^[6].
• EpiVacCorona's Commons category is recorded as EpiVacCorona^[7].
• EpiVacCorona's country of origin is recorded as Russia^[8].
• EpiVacCorona's route of administration is recorded as intramuscular injection^[9].
• EpiVacCorona's route of administration is recorded as deltoid muscle^[10].
• EpiVacCorona's route of administration is recorded as quadriceps femoris muscle^[11].
• EpiVacCorona's DrugBank ID is recorded as DB16439^[12].
• EpiVacCorona's described by source is recorded as Simple, Blind, Placebo-controlled, Randomized Study of the Safety, Reactogenicity and Immunogenicity of Vaccine Based on Peptide Antigens for the Prevention of COVID-19 (EpiVacCorona), in Volunteers Aged 18-60 Years (I-II Phase)^[13].
• EpiVacCorona's vaccine for is recorded as COVID-19^[14].
• EpiVacCorona's Google Knowledge Graph ID is recorded as /g/11kl2trk5m^[15].

Why It Matters

EpiVacCorona ranks in the top 2% of general entities by monthly Wikipedia readership (12 views/month).^[1] EpiVacCorona has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.^[16]